SC 13D/A

NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A

Company: Marker Therapeutics, Inc.
Filed: May 17, 2024
Accession Number: 0001072613-24-000515

View Document ↗ View on SEC.gov ↗